image
Healthcare - Medical - Healthcare Plans - NYSE - US
$ 321.52
-0.729 %
$ 89.4 B
Market Cap
31.22
P/E
1. INTRINSIC VALUE

Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans to on and off the public exchanges; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations.[ Read More ]

The intrinsic value of one CI stock under the base case scenario is HIDDEN Compared to the current market price of 322 USD, Cigna Corporation is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart CI

image
FINANCIALS
195 B REVENUE
8.05%
8.54 B OPERATING INCOME
-10.18%
5.16 B NET INCOME
-23.45%
11.8 B OPERATING CASH FLOW
36.47%
-5.17 B INVESTING CASH FLOW
-167.01%
-4.29 B FINANCING CASH FLOW
61.80%
63.7 B REVENUE
5.32%
1.73 B OPERATING INCOME
-28.19%
971 M NET INCOME
-37.27%
46 M OPERATING CASH FLOW
-82.64%
-776 M INVESTING CASH FLOW
-21.25%
439 M FINANCING CASH FLOW
119.01%
Balance Sheet Decomposition Cigna Corporation
image
Current Assets 37.4 B
Cash & Short-Term Investments 7.82 B
Receivables 17.7 B
Other Current Assets 11.8 B
Non-Current Assets 115 B
Long-Term Investments 12.8 B
PP&E 4.06 B
Other Non-Current Assets 98.5 B
Current Liabilities 48.7 B
Accounts Payable 8.55 B
Short-Term Debt 2.88 B
Other Current Liabilities 37.3 B
Non-Current Liabilities 57.7 B
Long-Term Debt 28.6 B
Other Non-Current Liabilities 29.1 B
EFFICIENCY
Earnings Waterfall Cigna Corporation
image
Revenue 195 B
Cost Of Revenue 36.3 B
Gross Profit 159 B
Operating Expenses 187 B
Operating Income 8.54 B
Other Expenses 3.37 B
Net Income 5.16 B
RATIOS
81.41% GROSS MARGIN
81.41%
4.37% OPERATING MARGIN
4.37%
2.65% NET MARGIN
2.65%
11.17% ROE
11.17%
3.38% ROA
3.38%
10.78% ROIC
10.78%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Cigna Corporation
image
Net Income 5.16 B
Depreciation & Amortization 3.04 B
Capital Expenditures -1.57 B
Stock-Based Compensation 286 M
Change in Working Capital 3.49 B
Others 2.55 B
Free Cash Flow 10.2 B
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Cigna Corporation
image
Wall Street analysts predict an average 1-year price target for CI of $384 , with forecasts ranging from a low of $354 to a high of $407 .
CI Lowest Price Target Wall Street Target
354 USD 10.10%
CI Average Price Target Wall Street Target
384 USD 19.59%
CI Highest Price Target Wall Street Target
407 USD 26.59%
4. DIVIDEND ANALYSIS
0.40% DIVIDEND YIELD
1.4 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership Cigna Corporation
image
Sold
0-3 MONTHS
922 K USD 1
3-6 MONTHS
11.7 M USD 4
6-9 MONTHS
44.4 M USD 6
9-12 MONTHS
17.3 M USD 3
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
2 months ago
Aug 19, 2024
Sell 922 K USD
DeLaney William J III
Director
- 2691
342.68 USD
3 months ago
Aug 12, 2024
Sell 7.29 M USD
Jones Nicole S
See Remarks
- 22030
330.96 USD
3 months ago
Aug 12, 2024
Sell 591 K USD
Triplett Michael W
Special Advisor
- 1785
330.96 USD
3 months ago
Aug 12, 2024
Sell 1.66 M USD
Triplett Michael W
Special Advisor
- 5034
329.5764 USD
4 months ago
Jun 24, 2024
Sell 1.65 M USD
Evanko Brian C
See Remarks
- 4795
345.0058 USD
5 months ago
Jun 17, 2024
Sell 181 K USD
Granger Elder
Director
- 547
331.38 USD
5 months ago
Jun 12, 2024
Sell 338 K USD
Granger Elder
Director
- 1000
338.08 USD
6 months ago
May 14, 2024
Sell 3.73 M USD
Eder Noelle K
See Remarks
- 10700
348.47 USD
6 months ago
May 14, 2024
Sell 2.07 M USD
Agoglia Hoeltzel Mary T
SVP Tax & Chief Acct. Officer
- 5946
348.7133 USD
7 months ago
Mar 21, 2024
Sell 814 K USD
Cordani David
Chairman & CEO
- 2293
355.016 USD
7 months ago
Mar 22, 2024
Sell 2.25 M USD
Cordani David
Chairman & CEO
- 6338
355.1092 USD
7 months ago
Mar 25, 2024
Sell 11.1 M USD
Cordani David
Chairman & CEO
- 31209
355.1654 USD
8 months ago
Mar 13, 2024
Sell 273 K USD
Cordani David
Chairman & CEO
- 789
345.6654 USD
8 months ago
Mar 13, 2024
Sell 311 K USD
Cordani David
Chairman & CEO
- 892
348.6585 USD
8 months ago
Mar 13, 2024
Sell 1.72 M USD
Cordani David
Chairman & CEO
- 4972
346.8791 USD
8 months ago
Mar 12, 2024
Sell 772 K USD
Cordani David
Chairman & CEO
- 2238
345.0049 USD
8 months ago
Mar 13, 2024
Sell 2.47 M USD
Cordani David
Chairman & CEO
- 7108
347.6541 USD
8 months ago
Mar 07, 2024
Sell 208 K USD
Cordani David
Chairman & CEO
- 600
346.6533 USD
8 months ago
Mar 07, 2024
Sell 626 K USD
Cordani David
Chairman & CEO
- 1812
345.4197 USD
8 months ago
Mar 08, 2024
Sell 967 K USD
Cordani David
Chairman & CEO
- 2801
345.1921 USD
8 months ago
Mar 04, 2024
Sell 1.48 M USD
Jones Nicole S
See Remarks
- 4436
332.62 USD
8 months ago
Mar 04, 2024
Sell 6.42 M USD
Cordani David
Chairman & CEO
- 19288
332.62 USD
8 months ago
Mar 04, 2024
Sell 650 K USD
Triplett Michael W
Special Advisor
- 1953
332.62 USD
8 months ago
Feb 26, 2024
Sell 34.7 K USD
Cordani David
Chairman & CEO
- 100
347.135 USD
8 months ago
Feb 26, 2024
Sell 1.22 M USD
Cordani David
Chairman & CEO
- 3524
346.3793 USD
8 months ago
Feb 23, 2024
Sell 2.18 M USD
Cordani David
Chairman & CEO
- 6319
345.2433 USD
8 months ago
Feb 26, 2024
Sell 2.36 M USD
Cordani David
Chairman & CEO
- 6829
345.3358 USD
8 months ago
Feb 27, 2024
Sell 690 K USD
Cordani David
Chairman & CEO
- 2000
345.0375 USD
9 months ago
Feb 13, 2024
Sell 2.07 M USD
Palmer Eric P
See Remarks
- 6083
340 USD
9 months ago
Feb 09, 2024
Sell 341 K USD
Palmer Eric P
See Remarks
- 1017
335.2568 USD
9 months ago
Feb 12, 2024
Sell 71.4 K USD
Cordani David
Chairman & CEO
- 213
335.3568 USD
9 months ago
Feb 12, 2024
Sell 217 K USD
Cordani David
Chairman & CEO
- 644
337.3712 USD
9 months ago
Feb 12, 2024
Sell 410 K USD
Cordani David
Chairman & CEO
- 1216
336.76 USD
9 months ago
Feb 09, 2024
Sell 12.8 M USD
Cordani David
Chairman & CEO
- 38065
335.2193 USD
9 months ago
Feb 07, 2024
Sell 1.61 M USD
Agoglia Hoeltzel Mary T
SVP Tax & Chief Acct. Officer
- 4867
330.48 USD
9 months ago
Feb 02, 2024
Sell 1.85 M USD
Palmer Eric P
See Remarks
- 5684
325 USD
1 year ago
Aug 29, 2023
Sell 1.06 M USD
Ryan Cynthia
EVP, CHRO
- 3768
282.22 USD
1 year ago
Aug 21, 2023
Sell 2.16 M USD
Jones Nicole S
EVP, General Counsel
- 7819
276.86 USD
1 year ago
Aug 08, 2023
Sell 3.56 M USD
Agoglia Hoeltzel Mary T
SVP Tax & Chief Acct. Officer
- 12250
291 USD
1 year ago
Aug 02, 2023
Sell 692 K USD
Evanko Brian C
EVP, Chief Financial Officer
- 2307
300 USD
1 year ago
Jul 19, 2023
Sell 3.88 M USD
Neville Everett
EVP, Solutions & Corp Devt.
- 13157
295.21 USD
1 year ago
Jul 19, 2023
Sell 445 K USD
Sanford Paul A
EVP Operations
- 1507
295.21 USD
1 year ago
Jul 10, 2023
Sell 129 K USD
Neville Everett
EVP, Solutions & Corp Devt.
- 466
277.61 USD
1 year ago
May 01, 2023
Sell 192 K USD
ZARCONE DONNA F
Director
- 757
253.29 USD
1 year ago
Mar 10, 2023
Sell 470 K USD
Triplett Michael W
President, U.S. Commercial
- 1731
271.67 USD
1 year ago
Mar 10, 2023
Sell 567 K USD
ZARCONE DONNA F
Director
- 2088
271.67 USD
1 year ago
Mar 10, 2023
Sell 810 K USD
Neville Everett
EVP, Solutions & Corp Devt.
- 2982
271.67 USD
1 year ago
Mar 10, 2023
Sell 87.5 K USD
Granger Elder
Director
- 322
271.67 USD
1 year ago
Mar 02, 2023
Sell 131 K USD
Neville Everett
EVP, Solutions & Corp Devt.
- 454
289 USD
1 year ago
Mar 02, 2023
Sell 192 K USD
Jones Nicole S
EVP, General Counsel
- 663
289 USD
1 year ago
Feb 27, 2023
Sell 236 K USD
Ryan Cynthia
EVP, CHRO
- 803
294.06 USD
1 year ago
Feb 27, 2023
Sell 521 K USD
Neville Everett
EVP, Solutions & Corp Devt.
- 1772
294.06 USD
1 year ago
Feb 27, 2023
Sell 5.92 M USD
Cordani David
Chairman & CEO
- 20148
294.06 USD
1 year ago
Feb 27, 2023
Sell 1.59 M USD
Jones Nicole S
EVP, General Counsel
- 5404
294.06 USD
1 year ago
Dec 16, 2022
Sell 987 K USD
Ryan Cynthia
EVP, CHRO
- 3009
327.95 USD
1 year ago
Dec 08, 2022
Sell 2.31 M USD
Sadler Jason D
Pres., International Markets
- 6886
335 USD
1 year ago
Dec 08, 2022
Sell 3.26 M USD
Sadler Jason D
Pres., International Markets
- 9781
333.09 USD
2 years ago
Oct 14, 2022
Sell 112 K USD
Sanford Paul A
EVP Operations
- 373
300 USD
2 years ago
Oct 14, 2022
Sell 1.2 M USD
Palmer Eric P
President & CEO, Evernorth
- 4000
300.001 USD
2 years ago
Aug 09, 2022
Sell 107 K USD
Sanford Paul A
EVP Operations
- 374
285 USD
2 years ago
Aug 09, 2022
Sell 2.02 M USD
Agoglia Hoeltzel Mary T
SVP Tax & Chief Acct. Officer
- 7044
286.891 USD
2 years ago
Aug 01, 2022
Sell 247 K USD
Neville Everett
EVP, Strat, Corp Dev/Solutions
- 902
273.98 USD
2 years ago
Jul 07, 2022
Sell 1.79 M USD
Palmer Eric P
President & CEO, Evernorth
- 6521
275 USD
2 years ago
Jul 07, 2022
Sell 1.4 M USD
Neville Everett
EVP, Strat, Corp Dev/Solutions
- 5094
275 USD
2 years ago
Jul 07, 2022
Sell 103 K USD
Sanford Paul A
EVP Operations
- 374
275 USD
2 years ago
Jul 08, 2022
Sell 2.66 M USD
Sadler Jason D
Pres., International Markets
- 9505
280 USD
2 years ago
Jun 28, 2022
Sell 934 K USD
Sadler Jason D
Pres., International Markets
- 3458
270 USD
2 years ago
May 17, 2022
Sell 10.7 M USD
Cordani David
Chairman & CEO
- 39488
270.2905 USD
2 years ago
May 17, 2022
Sell 1.59 M USD
Jones Nicole S
EVP, General Counsel
- 5901
270 USD
2 years ago
Apr 20, 2022
Sell 6.05 M USD
Cordani David
Chairman & CEO
- 22534
268.461 USD
2 years ago
Apr 20, 2022
Sell 1.57 M USD
Jones Nicole S
EVP, General Counsel
- 5918
265 USD
2 years ago
Apr 18, 2022
Sell 1.54 M USD
Jones Nicole S
EVP, General Counsel
- 5936
260 USD
2 years ago
Apr 18, 2022
Sell 1.58 M USD
Jones Nicole S
EVP, General Counsel
- 6134
258.1 USD
2 years ago
Apr 18, 2022
Sell 6.29 M USD
Cordani David
Chairman & CEO
- 24156
260.503 USD
2 years ago
Apr 06, 2022
Sell 2.03 M USD
Palmer Eric P
President & CEO, Evernorth
- 8126
250 USD
2 years ago
Apr 06, 2022
Sell 1.25 M USD
Sadler Jason D
Pres., International Markets
- 5000
250 USD
2 years ago
Apr 06, 2022
Sell 250 K USD
Neville Everett
EVP, Strat, Corp Dev/Solutions
- 999
250 USD
2 years ago
Mar 01, 2022
Sell 69.1 K USD
Neville Everett
EVP, Strat, Corp Dev/Solutions
- 289
239 USD
2 years ago
Feb 28, 2022
Sell 61.3 K USD
Neville Everett
EVP, Strat, Corp Dev/Solutions
- 268
228.7 USD
2 years ago
Feb 28, 2022
Sell 528 K USD
Jones Nicole S
EVP, General Counsel
- 2307
228.7 USD
2 years ago
Feb 28, 2022
Sell 2.3 M USD
Cordani David
Chairman & CEO
- 10069
228.7 USD
2 years ago
Jan 11, 2022
Sell 42 K USD
Neville Everett
EVP, Strategy and Business Dev
- 175
240 USD
2 years ago
Jan 03, 2022
Sell 1.1 M USD
Neville Everett
EVP, Strategy and Business Dev
- 4800
229.49 USD
3 years ago
Aug 11, 2021
Bought 106 K USD
ZARCONE DONNA F
Director
+ 500
211.588 USD
3 years ago
Aug 10, 2021
Bought 105 K USD
ZARCONE DONNA F
Director
+ 500
209.893 USD
3 years ago
Jun 28, 2021
Sell 1.15 M USD
Granger Elder
Director
- 4844
237.06 USD
3 years ago
Jun 14, 2021
Sell 740 K USD
Triplett Michael W
President, US Markets
- 3075
240.7024 USD
3 years ago
May 07, 2021
Sell 7.68 M USD
Cordani David
President & CEO
- 29392
261.2412 USD
3 years ago
May 07, 2021
Sell 8.52 M USD
Cordani David
President & CEO
- 32731
260.4537 USD
3 years ago
May 04, 2021
Sell 98.2 K USD
Cordani David
President & CEO
- 379
259.1934 USD
3 years ago
May 04, 2021
Sell 351 K USD
Cordani David
President & CEO
- 1367
256.4266 USD
3 years ago
May 04, 2021
Sell 859 K USD
Cordani David
President & CEO
- 3325
258.4242 USD
3 years ago
May 04, 2021
Sell 1.42 M USD
Cordani David
President & CEO
- 5510
257.519 USD
3 years ago
May 04, 2021
Sell 8.21 M USD
Cordani David
President & CEO
- 32191
255.1274 USD
3 years ago
Apr 21, 2021
Sell 219 K USD
Cordani David
President & CEO
- 854
256.2801 USD
3 years ago
Apr 21, 2021
Sell 1.37 M USD
Cordani David
President & CEO
- 5353
255.246 USD
3 years ago
Apr 15, 2021
Sell 601 K USD
Cordani David
President & CEO
- 2400
250.2771 USD
3 years ago
Apr 15, 2021
Sell 751 K USD
Cordani David
President & CEO
- 2942
255.3709 USD
7. News
Cigna Ends Humana Merger Speculation: CI Jumps 7.3% While HUM Slips CI reaffirms its 2024 outlook, projecting full-year adjusted EPS to be a minimum of $28.40. zacks.com - 5 days ago
3-Stock Lunch: Cigna, Coinbase, & Draft Kings Victoria Greene, G Squared Private Wealth CIO, joins CNBC's 'Power Lunch' to discuss three stocks: Cigna, Coinbase, and Draft Kings. youtube.com - 5 days ago
Why Cigna Stock Popped Today The healthcare company put merger rumors to bed. fool.com - 5 days ago
Why Cigna Deal With Humana Made Little Sense To Begin With The Cigna Group confirmed “it is not pursuing a combination with Humana.” forbes.com - 5 days ago
2 Healthcare Stocks in Focus After Merger Talks Break Down Shares of Humana Inc (NYSE:HUM) are down 3.7% at $277.38 at last glance, after Cigna Group (NYSE:CI) said it was not pursuing a merger with the smaller health insurance name, and will instead prioritize share buybacks. schaeffersresearch.com - 6 days ago
Cigna rallies after Humana mega-merger called off US health insurer Cigna has made the appropriate decision to ditch plans to merge with rival Humana (NYSE:HUM), if today's market reaction is anything to go by. Rumours of the merger, which would have created a $140 billion insurance behemoth, began circulating last December, but doubts over the deal quickly followed. proactiveinvestors.co.uk - 6 days ago
Humana Stock Tumbles. Cigna Won't Pursue the Health Insurer. Investors have long appeared skeptical about a potential merger between the two health insurers. barrons.com - 6 days ago
Cigna says it will not pursue combination with Humana Health insurer Cigna Group said on Monday it is not pursuing a combination with peer Humana. reuters.com - 6 days ago
The Cigna Group Affirming Its Capital Priorities Reaffirming Previously Provided Outlook for Full-Year 2024, and adjusted EPS growth of at least 10% in 2025 Confirming it is not Pursuing a Combination with Humana Inc. Confirming Continuing to Use Capital to Drive Shareholder Value, including Share Repurchase and Dividends BLOOMFIELD, Conn. , Nov. 11, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE: CI) officials expect to participate in meetings with investors and analysts over the next several weeks. prnewswire.com - 6 days ago
5 Relatively Secure And Cheap Dividend Stocks - November 2024: Yields Up To 9% This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering large discounts to their historical norms. We go over our filtering process to select just five conservative DGI stocks from more than 7,500 companies that are traded on U.S. exchanges, including OTC networks. In addition to the primary list that yields about 3.35%, we present two other groups of five DGI stocks each, from moderate to high yields of up to 9%. seekingalpha.com - 1 week ago
Cigna's Impressive Q3: 4 Compelling Reasons To Buy Now The Cigna Group's Q3 2024 results showed once again strong revenue and earnings growth. Yet, CI shares are down almost 20% from their 52-week-high. In this article, I will discuss the reasons for the once again favorable valuation of CI stock and explain why I seized what I believe to be a compelling opportunity. I will also give my opinion on the renewed speculation about a possible merger with Humana and explain why the concerns are likely unfounded. seekingalpha.com - 1 week ago
Here's Why Cigna (CI) is a Strong Value Stock Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. zacks.com - 1 week ago
8. Profile Summary

Cigna Corporation CI

image
COUNTRY US
INDUSTRY Medical - Healthcare Plans
MARKET CAP $ 89.4 B
Dividend Yield 0.40%
Description Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care delivery and management, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans to on and off the public exchanges; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. The company also offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. It distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Contact 900 Cottage Grove Road, Bloomfield, CT, 06002 https://www.cigna.com
IPO Date March 31, 1982
Employees 70325
Officers Ms. Noelle K. Eder Executive Vice President & Global Chief Information Officer Kari Knight Stevens Executive Vice President, Chief Human Resources Officer & Corporate Secretary Mr. Ralph Giacobbe Senior Vice President & Head of Investor Relations Mr. Jason D. Sadler President of International MArkets & President of International Health Cigna Healthcare Mr. Christopher DeRosa M.B.A. President of U.S. Government - Healthcare's Medicare & Individual & Family Plan (IFP) Businesses Mr. Phil Austin Head of Strategy & Global Business Development for Cigna International Markets Mr. Dean Morris Mirabella President and GM of Florida & Caribbean Markets Mr. Eric Paul Palmer Executive Vice President of Enterprise Strategy Ms. Jamie Kates Chief Accounting Officer Mr. David Michael Cordani President, Chief Executive Officer & Chair of the Board